Cosmo invites investors, financial analysts and business/life science journalists to a live video webcast presentation at
Live conference call and video webcast presentation
Date: Wednesday,
Time:
Participant webcast link: Chrome (recommended) or Firefox https://event.choruscall.com/mediaframe/webcast.htmlwebcastid=zZeEM8So
Please note that there is a function to type in your questions via webcast.
Via phone: Participants wishing to ask verbal questions via phone, may call the following numbers below. To ensure prompt access, please call approximately ten minutes prior to the scheduled start of the call.
The media release as well as the Half-Year Report 2024 will be available for download as of
Replay
The webcast, along with the presentation, will be available online shortly after the event and accessible for three months.
About Cosmo
Cosmo is a pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders, to improve endoscopy quality measures through aiding the detection of colonic lesions and to treat selected dermatological conditions. Cosmo develops and manufactures products which are distributed globally by selected partners including Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Aemcolo/ Relafalk, Lumeblue and Winlevi. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of GI Genius, which uses artificial intelligence to help detect potential signs of colon cancer. The company also has a rich development pipeline.
Contact:
Tel: +353 1 817 03 70
Email: hwinchester@cosmopharma.com
(C) 2024 Electronic News Publishing, source